Log In
Saturday 22nd October 2016

Money for drug watchdog

27th June 2008

The chairman of the National Institute for Health and Clinical Excellence (NICE) has told the BBC he thinks the organisation will receive more funding.

Drugs & Money

NICE decides which drugs can be offered and how patients are treated by the NHS in England, Wales and Northern Ireland.

Sir Michael Rawlins spoke to the BBC as a way of marking the 60th anniversary of the health service.

He said that by 2010 NICE will have finished 120 guidelines and they would need to revise them "every three or four years" to keep them relevant.

He added: "So we are proposing to the government that they invest much more heavily in our guidelines programme, so we can do a whole lot of further guidelines."

"This will mean we can considerably improve the quality of care patients get from the NHS."

The most recent controversy linked to NICE has been the "co-payments" issue, where a patient who receives private care is then refused health service treatment.

The issue is subject to a ministerial review in Scotland, Wales and England.

Sir Michael said the topic was one which needed to be discussed openly and that it was a complex issue.

"It is a political decision that parliament should decide, on behalf of people who use and pay for the NHS," he said.


Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Mayden - Innovative cloud-based web development for the healthcare sector
© Mayden Foundation 2016